Skip to main navigation
Neurogene Therapeutics
Contact Us
  • ABOUT US
  • TECHNOLOGY
  • PIPELINE
  • PATIENTS AND FAMILIES
  • INVESTORS
  • CAREERS
  • CONTACT US
  • TWITTER
  • LINKEDIN
  • FACEBOOK
  • Overview
  • News & Events
    • News Releases
    • Events & Presentations
  • Corporate Governance
    • Governance Overview
    • Leadership Team
    • Board of Directors
    • Committee Composition
  • Financial Information
    • SEC Filings
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Shareholder Services
    • Investor FAQs
    • Email Alerts
    • RSS Feeds
    • Investor Contacts

SEC Filing Details

  • Overview
  • News & Events
    • News Releases
    • Events & Presentations
  • Corporate Governance
    • Governance Overview
    • Leadership Team
    • Board of Directors
    • Committee Composition
  • Financial Information
    • SEC Filings
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Shareholder Services
    • Investor FAQs
    • Email Alerts
    • RSS Feeds
    • Investor Contacts

Document Details

Form
10-Q
Filing Date
Aug 19, 2021
Document Date
Aug 19, 2021
Filing Group
Quarterly Filings
Company
Neurogene Inc.
Filer
Test Filer

Filing Formats

View HTML
Download PDF 137.2 KB
Download XLS 9.5 KB

XBRL

EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
Neurogene Inc.

Corporate Headquarters
535 W 24th Street, 5th Floor
New York, NY 10011

Manufacturing Headquarters
Houston, TX 77025
 

© 2024 Neurogene Inc.
GL-GEN-WEB-0002v8

Contact Us
Translation Disclaimer
  • Privacy
  • Terms of Use